PA
AMRX icon

Profund Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Profund Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
25,540
-406
-2% -$5.56K 0.01% 604
2026
Q1 		$323K Buy
25,946
+2,582
+11% +$34.7K 0.01% 705
2025
Q4 		$294K Sell
23,364
-461
-2% -$5.28K 0.01% 888
2025
Q3 		$238K Sell
23,825
-4,691
-16% -$42.1K 0.01% 879
2025
Q2 		$231K Buy
28,516
+9,245
+48% +$69.7K 0.01% 821
2025
Q1 		$161K Sell
19,271
-1,825
-9% -$15.2K 0.01% 927
2024
Q4 		$167K Sell
21,096
-1,762
-8% -$14.8K 0.01% 1035
2024
Q3 		$190K Buy
22,858
+336
+1% +$2.63K 0.01% 1061
2024
Q2 		$143K Buy
22,522
+1,680
+8% +$10.7K 0.01% 1023
2024
Q1 		$126K Buy
20,842
+2,836
+16% +$16K ﹤0.01% 1117
2023
Q4 		$109K Buy
+18,006
New +$80.2K ﹤0.01% 1098
2021
Q3 		– Sell
-11,333
Closed -$59K – 1354
2021
Q2 		$59K Buy
11,333
+873
+8% +$4.96K ﹤0.01% 1413
2021
Q1 		$70K Buy
+10,460
New +$58K ﹤0.01% 1335
2020
Q1 		– Sell
-10,351
Closed -$50K – 795
2019
Q4 		$50K Buy
+10,351
New +$36K ﹤0.01% 1257
2019
Q1 		– Sell
-16,688
Closed -$226K – 1214
2018
Q4 		$226K Sell
16,688
-2,879
-15% -$51.9K 0.01% 960
2018
Q3 		$434K Buy
+19,567
New +$412K 0.02% 925

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Profund Advisors's AMRX Position: Q2 2026 in Review

Profund Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 1.6% in Q2 2026, selling an estimated $5.56K and leaving 25,540 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #604.

Profund Advisors first reported a position in AMRX in Q3 2018 and has held it in 16 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Profund Advisors held 25,540 shares of Amneal Pharmaceuticals worth $442K as of Q2 2026.
  • Profund Advisors sold 406 Amneal Pharmaceuticals shares in Q2 2026, an estimated $5.56K.
  • Amneal Pharmaceuticals made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #604 holding.
  • Profund Advisors first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 16 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.